Factors Associated with the Effects of Ipragliflozin on the Diurnal Profiles of Plasma Glucose and 3-hydroxybutyrate in Patients with Type 2 Diabetes

被引：0
|
作者：
Nakayama, Hitomi
Yoshinobu, Satoko
Kawano, Seiko
Tsuruta, Munehisa
Nohara, Masayuki
Hasuo, Rika
Akasu, Shoko
Tokubuchi, Ichiro
Wada, Nobuhiko
Hirao, Saori
Iwata, Shinpei
Kaku, Hiroo
Otabe, Shuichi
Tajiri, Yuji
Yamada, Kentaro
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1236-P
引用
收藏
页码：A320 / A320
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring
    Kawaguchi, Yuji
    Sawa, Jun
    Kumeda, Yasuro
    DIABETES THERAPY, 2020, 11 (12) : 2945 - 2958
  • [22] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
    Garg, SK
    Chase, HP
    Marshall, G
    DIABETES, 2001, 50 : A435 - A436
  • [23] Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring
    Yuji Kawaguchi
    Jun Sawa
    Yasuro Kumeda
    Diabetes Therapy, 2020, 11 : 2945 - 2958
  • [24] Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients
    Yun, Jun Ho
    Kim, Jeong-Min
    Jeon, Hyun Jeong
    Oh, Taekeun
    Choi, Hyung Jin
    Kim, Bong-Jo
    PLOS ONE, 2020, 15 (10):
  • [25] Diurnal Glucose Patterns Based on Continuous Glucose Monitoring of Patients With Type 2 Diabetes Treated With Colesevelam HCl
    Mazze, Roger
    Strock, Ellie
    Monk, Arlene
    Murphy, Matthew
    Bergenstal, Richard
    Xi, Min
    DIABETES, 2012, 61 : A301 - A301
  • [26] The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes
    Okura, Tsuyoshi
    Fujioka, Yohei
    Nakamura, Risa
    Kitao, Sonoko
    Ito, Yuichi
    Anno, Mari
    Matsumoto, Kazuhisa
    Shoji, Kyoko
    Matsuzawa, Kazuhiko
    Izawa, Shoichiro
    Okura, Hiroko
    Ueta, Etsuko
    Kato, Masahiko
    Imamura, Takeshi
    Taniguchi, Shin-ichi
    Yamamoto, Kazuhiro
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Effects of Piragliatin, a Glucokinase Activator, on Fasting and Postprandial Plasma Glucose in Patients With Type 2 Diabetes Mellitus
    Zhi, Jianguo
    Zhai, Suoping
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (02): : 231 - 238
  • [28] Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
    Konya, Hiroyuki
    Katsuno, Tomoyuki
    Tsunoda, Taku
    Yano, Yuzo
    Kamitani, Mai
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-Ichiro
    Namba, Mitsuyoshi
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 317 - 325
  • [29] DIURNAL-VARIATIONS IN CONCENTRATIONS OF BLOOD ACETOACETATE AND 3-HYDROXYBUTYRATE AND THEIR RELATION TO INSULIN, GROWTH-HORMONE, FREE FATTY-ACIDS AND GLYCEROL IN SERUM AND GLUCOSE IN PLASMA
    WILDENHO.KE
    SCHWARTZ.N
    JOHANSEN, JP
    DIABETOLOGIA, 1972, 8 (05) : 368 - &
  • [30] Factors associated to glycaemic control in patients with type 2 diabetes
    Panarotto, Daniel
    Teles, Alisson Roberto
    Schumacher, Marina Verdi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 314 - 321
12345